While we all speculate on what kind of "deal(s) IP

While we all speculate on what kind of "deal(s) IPIX is working on,
I'll throw my 2 cents in the ring as well.

I think a buyout is in the works.

I'm focusing on Pfizer and Novartis.Not just because they major in
cancer and dermatology but also because Dr.B has ties to both and knows
them well.
My main focus is Pfizer because back in the P1 of Kevetrin,there was
testing on a combo of Kevetrin and a Pfizer drug at (I believe) Beth-
Israel where the researchers said that it was the first time they tried
a therapy where actual tumor shrinkage was noted.That alone must have
excited Pfizer.
Both Pfizer and Novartis would,however have a great deal of interest in
all of Brilicidin as well as Kevetrin,and if Prurisol pans out it would
be a perfect trifecta.
I can't see Pfizer or Novartis cherrypicking here.They will want it all.

Will they meet Leo'sprice tag?I think so.These drugs are too valuable to
just let them slip away and get divvied up among multiple suitors.

Just MHO.

Kelt